{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T18:05:18Z","timestamp":1775844318256,"version":"3.50.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":321,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>In addition to hypocalcemia, patients with hypoparathyroidism report poor quality of life (QOL), complaining of fatigue and \u201cbrain fog.\u201d Parathyroid hormone (PTH) therapy can effectively manage hypocalcemia; however, the effects of PTH treatment on QOL are unclear. Thirty-one patients with hypoparathyroidism were treated in an open-label study with full replacement subcutaneous PTH 1-34 twice daily for up to 5.3\u2009years, with individualized fine-dosing titration. Prior to initiation of PTH 1-34, conventional therapy was optimized. The 36-Item Short Form (SF-36) Health Survey, Fatigue Symptom Inventory (FSI), and 6-minute walk test (6MWT) were assessed at PTH start (baseline), every 6\u2009months on PTH, and after PTH discontinuation. The SF-36 assesses physical function (PF), physical role limitations (RP), bodily pain (BP), general health (GH), vitality (VT), emotional role limitations (RE), social function (SF), and mental health (MH). Compared to population norms, patients at baseline had lower scores in RP, GH, VT, and MH (p\u00a0&amp;lt;\u20090.05), consistent with impaired QOL. With PTH therapy, only GH at 6\u2009months and VT at 12\u2009months improved (p\u00a0&amp;lt;\u20090.05). At the last treatment time point, RP, VT, and SF improved compared to baseline (p\u00a0&amp;lt;\u20090.05). However, follow-up scores were unchanged from baseline or last PTH treatment, except for SF, which had decreased at follow-up compared to on-PTH (p\u00a0&amp;lt;\u20090.05). On the FSI, there were no changes in fatigue frequency; perceived interference was improved at 12 and 18 months and composite severity was improved only at 60\u2009months (p\u00a0&amp;lt;\u20090.05). The 6MWT measures did not change. In conclusion, hypoparathyroidism is associated with decreased QOL. Despite the bias in open-label studies to predict improvements in QOL, PTH therapy had limited and non-sustained effects on QOL, inconclusive changes in fatigue experience, and no change in the 6MWT. Although PTH 1-34 can adequately manage the hypocalcemia in hypoparathyroidism, its effects on QOL appear to be minimal. \u00a9 2021 American Society for Bone and Mineral Research (ASBMR). This article has been contributed to by US Government employees and their work is in the public domain in the USA.<\/jats:p>","DOI":"10.1002\/jbmr.4452","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T09:32:07Z","timestamp":1632907927000},"page":"68-77","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["PTH 1-34 Replacement Therapy Has Minimal Effect on Quality of Life in Patients With Hypoparathyroidism"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0284-5299","authenticated-orcid":false,"given":"Kelly L.","family":"Roszko","sequence":"first","affiliation":[{"name":"National Institute of Dental and Craniofacial Research National Institutes of Health Bethesda MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany Y.","family":"Hu","sequence":"additional","affiliation":[{"name":"National Institute of Dental and Craniofacial Research National Institutes of Health Bethesda MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori C.","family":"Guthrie","sequence":"additional","affiliation":[{"name":"National Institute of Dental and Craniofacial Research National Institutes of Health Bethesda MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth A.","family":"Brillante","sequence":"additional","affiliation":[{"name":"National Institute of Dental and Craniofacial Research National Institutes of Health Bethesda MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaele","family":"Smith","sequence":"additional","affiliation":[{"name":"Rehabilitation Medicine Department, Clinical Center National Institutes of Health Bethesda MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3676-7644","authenticated-orcid":false,"given":"Michael T.","family":"Collins","sequence":"additional","affiliation":[{"name":"National Institute of Dental and Craniofacial Research National Institutes of Health Bethesda MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel I.","family":"Gafni","sequence":"additional","affiliation":[{"name":"National Institute of Dental and Craniofacial Research National Institutes of Health Bethesda MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"issue":"3","key":"2024012714040769500_jbmr4452-bib-0001","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1677\/joe.1.06057","article-title":"Parathyroid hormone: past and present","volume":"187","author":"Potts","year":"2005","journal-title":"J Endocrinol"},{"issue":"18","key":"2024012714040769500_jbmr4452-bib-0002","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMcp1800213","article-title":"Hypoparathyroidism","volume":"380","author":"Gafni","year":"2019","journal-title":"N Engl J Med"},{"issue":"10","key":"2024012714040769500_jbmr4452-bib-0003","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/jbmr.483","article-title":"Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research","volume":"26","author":"Bilezikian","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2024012714040769500_jbmr4452-bib-0004","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMcp0803050","article-title":"Clinical practice. Hypoparathyroidism","volume":"359","author":"Shoback","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"2024012714040769500_jbmr4452-bib-0005","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ecl.2018.07.010","article-title":"Quality of life in hypoparathyroidism","volume":"47","author":"Vokes","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"2024012714040769500_jbmr4452-bib-0006","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cen.14128","article-title":"Burden of illness in not adequately controlled chronic hypoparathyroidism: findings from a 13-country patient and caregiver survey","volume":"92","author":"Siggelkow","year":"2020","journal-title":"Clin Endocrinol"},{"issue":"11","key":"2024012714040769500_jbmr4452-bib-0007","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/jbmr.2273","article-title":"Postsurgical hypoparathyroidism\u2014risk of fractures, psychiatric diseases, cancer, cataract, and infections","volume":"29","author":"Underbjerg","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2024012714040769500_jbmr4452-bib-0008","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/jbmr.2812","article-title":"Concurrent hypoparathyroidism is associated with impaired physical function and quality of life in hypothyroidism","volume":"31","author":"Sikjaer","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2024012714040769500_jbmr4452-bib-0009","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/cen.13593","article-title":"Health-related quality of life in patients with nonsurgical hypoparathyroidism and pseudohypoparathyroidism","volume":"88","author":"Underbjerg","year":"2018","journal-title":"Clin Endocrinol"},{"issue":"6","key":"2024012714040769500_jbmr4452-bib-0010","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1530\/EJE-12-0946","article-title":"Neuropsychological dysfunction in idiopathic hypoparathyroidism and its relationship with intracranial calcification and serum total calcium","volume":"168","author":"Aggarwal","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2024012714040769500_jbmr4452-bib-0011","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jbmr.2501","article-title":"The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study","volume":"30","author":"Underbjerg","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2024012714040769500_jbmr4452-bib-0012","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4158\/EP13328.OR","article-title":"Understanding the burden of illness associated with hypoparathyroidism reported among patients in the PARADOX study","volume":"20","author":"Hadker","year":"2014","journal-title":"Endocr Pract"},{"issue":"3","key":"2024012714040769500_jbmr4452-bib-0013","first-page":"319","article-title":"Self-report of psychological symptoms in hypoparathyroidism patients on conventional therapy","volume":"62","author":"Arneiro","year":"2018","journal-title":"Arch Endocrinol Metab"},{"issue":"2","key":"2024012714040769500_jbmr4452-bib-0014","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/eje.0.1460215","article-title":"Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D","volume":"146","author":"Arlt","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2024012714040769500_jbmr4452-bib-0015","doi-asserted-by":"crossref","first-page":"E1465","DOI":"10.1152\/ajpendo.00487.2006","article-title":"Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidism","volume":"292","author":"Reppe","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"2024012714040769500_jbmr4452-bib-0016","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3181\/00379727-176-41894","article-title":"Intact and carboxyterminal PTH do not cross the blood-cerebrospinal fluid barrier","volume":"176","author":"Akmal","year":"1984","journal-title":"Proc Soc Exp Biol Med"},{"issue":"6","key":"2024012714040769500_jbmr4452-bib-0017","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1210\/jc.2015-3910","article-title":"Management of hypoparathyroidism: present and future","volume":"101","author":"Bilezikian","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024012714040769500_jbmr4452-bib-0018","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1210\/jc.2015-3907","article-title":"Management of hypoparathyroidism: summary statement and guidelines","volume":"101","author":"Brandi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024012714040769500_jbmr4452-bib-0019","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1210\/jc.2017-02593","article-title":"Does PTH replacement therapy improve quality of life in patients with chronic hypoparathyroidism?","volume":"103","author":"Winer","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024012714040769500_jbmr4452-bib-0020","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1210\/jc.2013-1239","article-title":"The effect of PTH(1-84) on quality of life in hypoparathyroidism","volume":"98","author":"Cusano","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2024012714040769500_jbmr4452-bib-0021","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1210\/jc.2014-2267","article-title":"PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5\u2009years of therapy","volume":"99","author":"Cusano","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024012714040769500_jbmr4452-bib-0022","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1210\/jc.2018-02430","article-title":"Quality of life in hypoparathyroidism improves with rhPTH(1\u201384) throughout 8\u2009years of therapy","volume":"104","author":"Tabacco","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2024012714040769500_jbmr4452-bib-0023","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1210\/jc.2015-1855","article-title":"PTH(1-34) for surgical Hypoparathyroidism: a prospective, open-label investigation of efficacy and quality of life","volume":"100","author":"Santonati","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024012714040769500_jbmr4452-bib-0024","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00198-014-2677-6","article-title":"Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial","volume":"25","author":"Sikjaer","year":"2014","journal-title":"Osteopor Int"},{"issue":"2","key":"2024012714040769500_jbmr4452-bib-0025","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1210\/jc.2017-01471","article-title":"Recombinant human parathyroid hormone effect on health-related quality of life in adults with chronic hypoparathyroidism","volume":"103","author":"Vokes","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2024012714040769500_jbmr4452-bib-0026","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2024012714040769500_jbmr4452-bib-0027","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/jbmr.3480","article-title":"Hypocitraturia is an untoward side effect of synthetic human parathyroid hormone (hPTH) 1-34 therapy in hypoparathyroidism that may increase renal morbidity","volume":"33","author":"Gafni","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2024012714040769500_jbmr4452-bib-0028","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1210\/jc.2017-01555","article-title":"PTH(1-34) for surgical hypoparathyroidism: a 2-year prospective, open-label investigation of efficacy and quality of life","volume":"103","author":"Palermo","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024012714040769500_jbmr4452-bib-0029","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40271-019-00388-5","article-title":"Assessing the patient experience of hypoparathyroidism symptoms: development of the hypoparathyroidism patient experience scale-symptom (HPES-symptom)","volume":"13","author":"Brod","year":"2019","journal-title":"Patient"},{"issue":"1","key":"2024012714040769500_jbmr4452-bib-0030","doi-asserted-by":"crossref","first-page":"e10245","DOI":"10.1002\/jbm4.10245","article-title":"The HPQ-development and first administration of a questionnaire for hypoparathyroid patients","volume":"4","author":"Wilde","year":"2020","journal-title":"JBMR Plus"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbmr.4452","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jbmr.4452","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/37\/1\/68\/55459735\/jbmr4452.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/37\/1\/68\/55459735\/jbmr4452.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T11:08:07Z","timestamp":1710328087000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/37\/1\/68-77\/7512176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,9,29]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.4452","relation":{"has-review":[{"id-type":"doi","id":"10.1002\/JBMR.4452\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4452\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4452\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4452\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4452\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4452\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4452\/v2\/response1","asserted-by":"object"}]},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12,1]]},"published":{"date-parts":[[2020,12,1]]},"assertion":[{"value":"2021-03-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}